|
History:
Alborz Investment Corporation,
the first corporation to enter Tehran stock exchange, is
in possession of Pharmaceutical import, manufacturing and
distribution companies and has practically been
providing Iranian pharmaceutical needs. In order to
fulfill its mission, complete the supply chain and
support its subsidiary companies, the corporation
developed and established, “Alborz Bulk”, minimizing
import requirements and technical independence of our
valuable
Country, Iran.
The factory is located 100km from Tehran, in the
industrial city of Kaveh.
Constructed on an area of 20,000 m2 with an
investment of 90 million USD make Alborz Bulk one
of the greatest Active pharmaceutical Ingredient
manufacturers in Iran.
Vision:
Alborz Bulk Pharmaceutical Co.
Seriously attempts to be one of the top three API
manufacturers in Iran by applying Total quality
management (TQM) and Excellency methods and requirements
, state of the art technology with creating competitive
advantages in the products and sustainable quality
improvements . Also creative of value helped to improve
business development and providing better services to
all our customer and partners.
Targeting, quality, customer orientation, team work and
keeping the environment safe are our fundamental
principals.
Mission:
Alborz Bulk Co. is aiming to
produce pharmaceutical active ingredients (API) based on
international standards and in compliance with
environmental considerations and safety precautions
using the most recent technologies and the scientific
and experimental capabilities of its personnel.
Creating value for its customers and stakeholders and
keeping up to a continuous improvement of quality to
achieve the Excellency are also listed on the company’s
main approach.
Goal Objectives:
- Attraction, promotion and
sustainability of customers’ satisfaction by identifying
their need and meeting them in regard to legal
regulations.
- Improving the quality of products and services putting
continuous improvement methods in work and organization
Excellency models as well.
- Keeping up to the most recent science and technology
to produce products and services in tone with changes
and growth trends of pharmaceutical market in region and
nation.
- Endeavor in eliminating country’s dependence and
minimizing import of active pharmaceutical ingredients.
|
